Clinical trial
GRANDMASTER: Gauging the Role of Alertness and Neurostimulation With Dietary Caffeine in Master-Level Chess; A Double-Blind Randomized Crossover Trial
NCT07641335 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GRANDMASTER: Gauging the Role of Alertness and Neurostimulation With Dietary Caffeine in Master-Level Chess; A Double-Blind Randomized Crossover Trial
- Lead sponsor
- St. Louis University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 25, 2026
- Completion date
- August 30, 2027
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention, caffeine, cognitive performance, reaction time